Wuhua Zhou
Overview
Explore the profile of Wuhua Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Q, Pan C, Zhou Y, Wang S, Xie L, Zhou W, et al.
Hepatology
. 2023 Feb;
78(5):1402-1417.
PMID: 36811396
Background Aims: Regulatory T cells (Tregs) are an obstacle to PD-1 blockade-mediated antitumor efficacy. However, the behaviors of Tregs response to anti-PD-1 in HCC and the characteristics of Tregs tissue...
2.
Qian J, Chen T, Wu Q, Zhou L, Zhou W, Wu L, et al.
Cancer Lett
. 2020 Oct;
498:242.
PMID: 33109412
No abstract available.
3.
Qian J, Chen T, Wu Q, Zhou L, Zhou W, Wu L, et al.
Cancer Lett
. 2020 Sep;
495:1-11.
PMID: 32949680
As a promising method for local tumor treatment, nanosecond pulsed electric field (nsPEF) ablation elicits a potent anti-tumor immune response. However, the mechanism of the nsPEF-mediated anti-tumor immune response and...
4.
Zhou W, Gong L, Wu Q, Xing C, Wei B, Chen T, et al.
J Exp Clin Cancer Res
. 2019 Nov;
38(1):445.
PMID: 31666106
In the publication of our publication [1], we have noticed there is a wrong label in Fig. 1e, in which the position of "HCC" and "Adjacent" should be transposed.
5.
Wang Y, Yin S, Zhou Y, Zhou W, Chen T, Wu Q, et al.
Int J Med Sci
. 2019 Oct;
16(9):1271-1282.
PMID: 31588193
Nanosecond pulsed electric fields (nsPEFs) is emerged as a potential curative modality to ablate hepatocellular carcinoma (HCC). The application of local ablation is usually limited by insufficiency of liver function....
6.
Zhou Y, Wang Y, Zhou W, Chen T, Wu Q, Chutturghoon V, et al.
Cancer Cell Int
. 2019 Jul;
19:179.
PMID: 31337986
Background: Multi-drug resistance is the major cause of chemotherapy failure in hepatocellular carcinoma (HCC). YAP, a critical effector of the Hippo pathway, has been shown to contribute to the progression,...
7.
Chen T, Zhou L, Zhou Y, Zhou W, Huang H, Yin S, et al.
Int J Biol Sci
. 2019 Jun;
15(6):1139-1147.
PMID: 31223275
Holliday Junction Recognition Protein (HJURP) is involved in various cancers including hepatocellular carcinoma (HCC). Current studies have showed that HJURP is correlated with HCC proliferation. However, the role of HJURP...
8.
Wu Q, Zhou W, Yin S, Zhou Y, Chen T, Qian J, et al.
Hepatology
. 2019 Feb;
70(1):198-214.
PMID: 30810243
Tumor-associated macrophages (TAMs) are recognized as antitumor suppressors, but how TAMs behave in the hypoxic environment of hepatocellular carcinoma (HCC) remains unclear. Here, we demonstrated that hypoxia inducible factor 1α...
9.
Zhou W, Gong L, Wu Q, Xing C, Wei B, Chen T, et al.
J Exp Clin Cancer Res
. 2018 Nov;
37(1):270.
PMID: 30404655
In the publication of this article [1], there are two inadvertent errors.
10.
Zhou W, Gong L, Wu Q, Xing C, Wei B, Chen T, et al.
J Exp Clin Cancer Res
. 2018 Sep;
37(1):215.
PMID: 30180906
Background: Plant homeodomain finger protein 8 (PHF8) serves an activator of epithelial-mesenchymal transition (EMT) and is implicated in various tumors. However, little is known about PHF8 roles in hepatocellular carcinoma...